Post-Approval Study of the HeartLight Endoscopic Ablation System for the Treatment of Atrial Fibrillation
Post-Approval Study of the HeartLight Endoscopic Ablation System for the Treatment of Atrial Fibrillation
This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.
This is a prospective, open-label, multi-center, single arm study designed to assess continued safety and effectiveness of the HeartLight System during commercial use in participants being treated for drug refractory, symptomatic, paroxysmal atrial fibrillation.
Inclusion Criteria:
Exclusion Criteria:
lhausmann@cardiofocus.com508-658-7253
Tucson, Arizona 85724, United States
betsy.ellsworth@mountsinai.org
MJS7W@hscmail.mcc.virginia.edu434-982-6401